2023
Long-term Incidence of Myocardial Infarction and Death After CABG and PCI for Isolated Left Anterior Descending Artery Disease: A Meta-analysis of Randomized Controlled Trials
Prasad M, Ahmad Y, Howard J, Ben-Ami J, Madhavan M, Kirtane A, McEntegart M, Flattery E, Stone G, Leon M, Moses J. Long-term Incidence of Myocardial Infarction and Death After CABG and PCI for Isolated Left Anterior Descending Artery Disease: A Meta-analysis of Randomized Controlled Trials. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100636. DOI: 10.1016/j.jscai.2023.100636.Peer-Reviewed Original ResearchPercutaneous coronary interventionLong-term incidenceMyocardial infarctionLAD diseaseArtery diseaseLeft anterior descending (LAD) coronary artery diseaseAnterior descending (LAD) coronary artery diseaseLeft internal mammary artery graftInternal mammary artery graftRisk of MIMammary artery graftsCoronary artery bypassCoronary artery diseaseRandomized Controlled TrialsSignificant differencesArtery bypassArtery graftCause mortalityVessel revascularizationCoronary interventionSecondary outcomesControlled TrialsLeft anteriorPrimary outcomeCABG
2021
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials
Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. European Heart Journal 2021, 42: 2643-2654. PMID: 34002202, PMCID: PMC8282325, DOI: 10.1093/eurheartj/ehab280.Peer-Reviewed Original ResearchConceptsThin-strut drug-eluting stentsUltrathin-strut drug-eluting stentsTarget lesion failureDrug-eluting stentsStent thrombosisMyocardial infarctionCardiac deathCause mortalityCD-TLRRisk of TLFSystematic reviewPre-specified primary endpointRisk of MIRevascularization of patientsWeighted mean followTarget lesion revascularizationPercutaneous coronary interventionStandard of careNew trial dataCause deathLesion revascularizationEligible trialsLesion failureMean followPrimary endpoint